Lifetime Omics

Lifetime Omics is a United States biotech and health-informatics company headquartered in Miami, Florida. According to its own materials, it models living organisms as multidimensional datasets and decodes them through AI-driven life sciences. In healthcare, the company frames human health through the lens of the "Pan-Ome" — the totality of genomic, environmental, and clinical data — and describes its mission as integrating, analyzing, and optimizing that data for research and clinical use. The company's flagship technology is FAIRLYZ, a platform it describes as pioneering infrastructure designed to give researchers access to a network of high-fidelity omics data. A cornerstone of the FAIRLYZ approach is an on-premises "data-visiting" model intended to protect Protected Health Information (PHI) while generating metadata and purpose-built digital twins. By working with abstracted models rather than raw patient records, Lifetime Omics aims to let researchers train sophisticated algorithms on realistic biological patterns without exposing sensitive data. The company positions FAIRLYZ as infrastructure for a continuum of clinical AI — from focused laboratory datasets to the integration of treatments, real-time wearables, and sensor technology for individualized care. Beyond FAIRLYZ, Lifetime Omics markets a set of health and wellness offerings organized around the "Omics-Gut-Brain Axis," linking foods to moods and addressing immune health. It also promotes CLAIRE, described as a clinical AI system for real-time engagement, and a Health-As-A-Service model. The company's public FAQ explains core concepts such as omics, the gut–brain axis, and clinical AI systems, reflecting an educational and thought-leadership posture alongside its technology products. Lifetime Omics presents itself as a multidisciplinary organization staffed by scientists, engineers, biomedical researchers, and data specialists. It operates in the intersection of biotechnology, health informatics, and clinical artificial intelligence, targeting medical researchers, healthcare providers, and life-sciences partners. Its business model combines data infrastructure, AI systems, and health services. The company is privately held; no parent company, founder, or founding year is confirmed in the available evidence.

Lifetime Omics is a privately held biotech and health-informatics company based in Miami, Florida, in the United States. Public evidence does not establish a founding year, founder, or detailed corporate chronology; the available record consists primarily of the company's own website and a Wikidata entry identifying it as a company in Miami. From its public materials, Lifetime Omics has positioned itself at the intersection of AI-driven life sciences and healthcare data infrastructure. Its stated approach is to model living organisms as multidimensional datasets and to view human health through the "Pan-Ome" — the totality of genomic, environmental, and clinical data. This framing reflects the broader multi-omics movement in biotechnology, in which genomics, transcriptomics, proteomics, metabolomics, and related disciplines are integrated to explain phenotypes as the product of biology, the exposome, and time. The company's central commercial effort is FAIRLYZ, which it describes as a pioneering technology designed to provide researchers with access to a network of high-fidelity omics data. Lifetime Omics states that it is "currently scaling" FAIRLYZ, indicating that the platform is in a growth or commercialization phase rather than a mature, widely deployed standard. A defining architectural choice is an on-premises data-visiting approach: rather than moving raw patient data to a central repository, the system generates metadata and purpose-built digital twins on site, allowing algorithms to be trained on abstracted models without exposing Protected Health Information. This privacy-preserving design is presented as a robust layer of protection for PHI and as the mechanism that enables cross-disciplinary analysis and secure sharing of abstracted models. Lifetime Omics situates FAIRLYZ within what it calls a progressive continuum of clinical AI. At one end are the focused datasets of laboratory scientists; at the other is the integration of treatments, real-time wearables, and sensor technology for individualized care. FAIRLYZ is offered as the infrastructure that bridges these silos, with the goal of accelerating scientific breakthroughs and translating them directly into bedside care. The company argues that reliable clinical AI systems must be trained on a quality-controlled, integrated synthesis of Electronic Health Records, multi-omics, medical imaging, and clinical trial results. Alongside FAIRLYZ, Lifetime Omics markets CLAIRE, described as a clinical AI system for real-time engagement, and a Health-As-A-Service model. It also organizes consumer-facing or wellness-oriented content around the "Omics-Gut-Brain Axis," connecting foods to moods and addressing immune health. Its website includes an FAQ explaining omics, the gut–brain axis, and clinical AI systems, indicating an educational component to its market development. The company describes its team as multidisciplinary, comprising scientists, engineers, biomedical researchers, and data specialists. No funding rounds, partnerships, acquisitions, leadership changes, or public listings are documented in the available evidence. As of the latest available information, Lifetime Omics remains an active, privately held company headquartered in Miami.

AI-driven biotech and health-informatics infrastructure bridging multi-omics, EHR, imaging, and clinical trial data through privacy-preserving digital twins and clinical AI systems.

• FAIRLYZ

  A pioneering technology platform designed to provide researchers with access to a network of high-fidelity omics data. It uses an on-premises data-visiting approach to protect Protected Health Information (PHI) while generating metadata and purpose-built digital twins, enabling algorithm training on abstracted models without exposing raw patient data.

• CLAIRE

  Described as a clinical AI system for real-time engagement, listed among the company's healthcare offerings.

• Health-As-A-Service

  A service model offered by Lifetime Omics alongside its platform and clinical AI products.

• Omics-Gut-Brain Axis offerings

  Health and wellness content and offerings connecting foods to moods and addressing immune health through the gut–brain axis.

1. 1Science in the Era of AI - Lifetime Omicslifetimeomics.com
2. 2About Us - Lifetime Omicslifetimeomics.com
3. 3Lifetime Omics (United States) - Wikidatawikidata.org